GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » Shares Outstanding (EOP)

FBLG (FibroBiologics) Shares Outstanding (EOP) : 33.92 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. FibroBiologics's shares outstanding for the quarter that ended in Sep. 2024 was 33.92 Mil.

FibroBiologics's quarterly shares outstanding increased from Jun. 2024 (32.72 Mil) to Sep. 2024 (33.92 Mil). It means FibroBiologics issued new shares from Jun. 2024 to Sep. 2024 .

FibroBiologics's annual shares outstanding increased from Dec. 2022 (32.48 Mil) to Dec. 2023 (32.49 Mil). It means FibroBiologics issued new shares from Dec. 2022 to Dec. 2023 .


FibroBiologics Shares Outstanding (EOP) Historical Data

The historical data trend for FibroBiologics's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Shares Outstanding (EOP) Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
Shares Outstanding (EOP)
32.48 32.48 32.49

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 32.48 32.49 32.72 32.72 33.92

Competitive Comparison of FibroBiologics's Shares Outstanding (EOP)

For the Biotechnology subindustry, FibroBiologics's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FibroBiologics's Shares Outstanding (EOP) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FibroBiologics's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where FibroBiologics's Shares Outstanding (EOP) falls into.



FibroBiologics Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


FibroBiologics  (NAS:FBLG) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


FibroBiologics Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroBiologics Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.